Published in J Neurochem on July 01, 1980
Respiration in vitro of synaptosomes from mammalian cerebral cortex. J Neurochem (1969) 2.08
Mutation in a calpain-like protease affects the posttranslational mannosylation of phosphatases in Aspergillus nidulans. Fungal Genet Biol (2003) 1.52
The inhibitory effect of sodium n-dipropyl acetate on the degradative enzymes of the GABA shunt. FEBS Lett (1975) 1.44
Metabolism of glucose and glutamate by synaptosomes from mammalian cerebral cortex. J Neurochem (1969) 1.24
Ionic basis for the depolarization of cerebral tissues by excitatory acidic amino acids. J Neurochem (1966) 1.16
Glutamine--a major substrate for nerve endings. J Neurochem (1978) 1.16
Metabolic response of synaptosomes to electrical stimulation: release of amino acids. Brain Res (1970) 1.13
The metabolism of glucose 6-phosphate by mammalian cerebral cortex in vitro. Biochem J (1971) 1.09
Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals. Brain Res (1978) 1.07
Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies. J Neurochem (1983) 1.07
Metabolism of beds of mammalian cortical synaptosomes: response to depolarizing influences. J Neurochem (1972) 1.06
Specific release of endogenous glutamate from piriform cortex stimulated in vitro. Brain Res (1976) 1.06
In vivo release from cerebral cortex of [14C]glutamate synthesized from [U-14C]glutamine. J Neurochem (1983) 1.00
Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem (1992) 1.00
Stimulated incorporation of amino acids into proteins of synaptosomal fractions induced by depolarizing treatments. J Neurochem (1977) 0.96
Depolarizing stimuli and the release of physiologically active amino acids from suspensions of mammalian synaptosomes. J Neurochem (1973) 0.93
Constituents of a microsomal fraction from the mammalian brain: their solubilization, especially by detergents. Biochem J (1964) 0.92
Tetanus toxin inhibits amino acid release from nerve endings in vitro. Nat New Biol (1973) 0.90
The stimulus-induced release of acetylcholine from synaptosome beds and its calcium dependence. J Neurochem (1972) 0.89
Actions of tremorgenic fungal toxins on neurotransmitter release. J Neurochem (1980) 0.87
The inflammatory stimulus of a natural latex biomembrane improves healing in mice. Braz J Med Biol Res (2011) 0.86
Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology (1995) 0.86
Patterns of amino acid release from nerve-endings isolated from spinal cord and medulla. J Neurochem (1973) 0.85
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV). Brain Res (1998) 0.85
Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure. J Ethnopharmacol (1988) 0.84
On glutaminase activity in mammalian synaptosomes. Brain Res (1976) 0.84
On the site of origin of transmitter amino acids released by depolarization of nerve terminals in vitro. J Neurochem (1977) 0.84
The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo. Brain Res (1980) 0.84
Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res (1998) 0.84
Inhibition of acute nociceptive responses in rats after i.c.v. injection of Thr6-bradykinin, isolated from the venom of the social wasp, Polybia occidentalis. Br J Pharmacol (2007) 0.84
Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol (1988) 0.83
Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol (1997) 0.83
The distribution of cation-stimulated adenosine triphosphatase in subcellular fractions from bovine cerebral cortex. J Neurochem (1966) 0.83
Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. J Neurochem (1995) 0.82
Participation of intracellular sites in the action of Ca2+ channel blockers. Eur J Pharmacol (1986) 0.82
Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res (2000) 0.82
Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J Neurochem (1980) 0.82
Glucose and amino acid metabolism in some invertebrate nervous systems. J Neurochem (1969) 0.82
The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Brain Res Dev Brain Res (1996) 0.82
Chronic phlebopathic cutaneous ulcer: a therapeutic proposal. Int J Dermatol (2001) 0.81
Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor. Brain Res Dev Brain Res (2001) 0.81
On the specificity of verapamil as a calcium channel-blocker. Biochem Pharmacol (1985) 0.81
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro. Brain Res Dev Brain Res (1994) 0.81
Excitatory amino acid receptors and depolarization-induced Ca2+ influx into hippocampal slices. J Neurochem (1987) 0.81
Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br J Pharmacol (1986) 0.81
Evidence for presynaptic cholinergic receptors on dopaminergic terminals: degeneration studies with 6-hydroxydopamine. Neurosci Lett (1979) 0.81
Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res (1997) 0.81
Oral treatment with Hev b 13 ameliorates experimental colitis in mice. Clin Exp Immunol (2012) 0.81
The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res (1994) 0.81
Actions of a tremorgenic mycotoxin on amino acid transmitter release in vivo. Biochem Pharmacol (1982) 0.81
Relative activities of glutamine synthetase and glutaminase in mammalian synaptosomes. J Neurochem (1979) 0.81
Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA. Biochem Pharmacol (1981) 0.81
Enhancement of depolarization-induced synaptosomal calcium uptake and neurotransmitter release by Bay K8644. Biochem Pharmacol (1986) 0.81
Compartmentation of synaptosomal dopamine. Adv Biochem Psychopharmacol (1978) 0.80
Studies on cigarette smoke induced oxidative DNA damage and reduced spermatogenesis in rats. J Environ Biol (2014) 0.80
Depolarisation-induced changes in muscarinic cholinergic receptors in synaptosomes. Nature (1979) 0.80
Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochem Res (1992) 0.80
Co-release of acetylcholine, glutamate and taurine from synaptosomes of Torpedo electric organ. Neurosci Lett (1987) 0.80
The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture. Neuroreport (2000) 0.80
Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes. Biochem Pharmacol (1981) 0.80
Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro. Neurosci Lett (2000) 0.80
Dopamine inhibition of the release of endogenous acetylcholine from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response? J Neurochem (1982) 0.79
The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Res (1983) 0.79
Effects of the crude venom of the social wasp Agelaia vicina on gamma-aminobutyric acid and glutamate uptake in synaptosomes from rat cerebral cortex. J Biochem Mol Toxicol (2000) 0.79
Effects of anticonvulsants on the in vivo and in vitro release of GABA. Biochem Pharmacol (1981) 0.79
Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res (1995) 0.79
N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J Neurochem (1993) 0.79
Common anticonvulsants inhibit Ca2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia (1987) 0.79
Isolation of toxin TsTX-VI from Tityus serrulatus scorpion venom. Effects on the release of neurotransmitters from synaptosomes. Biochem Mol Biol Int (1996) 0.79
Actions of Ptychodiscus brevis red tide toxin on metabolic and transmitter-releasing properties of synaptosomes. J Neurochem (1982) 0.79
Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. Eur J Pharmacol (1995) 0.79
Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: applications in cell replacement treatment for Parkinson's disease. Prog Neurobiol (2005) 0.79
The depolarisation-induced release of [125I]BDNF from brain tissue. Brain Res (1996) 0.78
N-methyl-D-aspartate releases excitatory amino acids in rat corpus striatum in vivo. J Neurochem (1991) 0.78
Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system. Prog Neurobiol (1997) 0.78
Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. Brain Res Dev Brain Res (1997) 0.78
Inhibition of depolarization-coupled calcium fluxes and transmitter release in vitro by morphine. FEBS Lett (1982) 0.78
The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling. Eur J Pharmacol (1997) 0.78
Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J Neurochem (1988) 0.78
Effect of alpha-amino-4-phosphonobutyrate on the release of endogenous glutamate and aspartate from cortical synaptosomes of epileptic rats. J Neurochem (1985) 0.78
Convulsions and activation of epileptic foci induced by monosodium glutamate and related compounds. Biochem Pharmacol (1977) 0.78
Preloading in vivo: a rapid and reliable method for measuring gamma-aminobutyric acid and glutamate fluxes by microdialysis. J Neurochem (1990) 0.77
The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. Eur J Pharmacol (1997) 0.77
Excitatory amino acid neurotransmitters in the corticostriate pathway: studies using intracerebral microdialysis in vivo. J Neurochem (1986) 0.77
Metabolic and secretory processes in nerve-endings isolated from post-mortem brain. Neurosci Lett (1979) 0.77
Effect of beta-bungarotoxin on the release of endogenous amino aids from the sensorimotor cortex. J Neurochem (1981) 0.77
Absence of an effect of histamine, noradrenaline and depolarizing agents on the levels of adenosine 3', 5'-monophosphate in nerve endings isolated from cerebral cortex. Biochem Pharmacol (1974) 0.77
Induction of tyrosine hydroxylase gene expression in human foetal cerebral cortex. Neurosci Lett (1998) 0.77
Lack of effect of focally administered prostaglandins on electrically kindled seizure activity. Prostaglandins (1991) 0.77
Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. Biochem Pharmacol (1986) 0.77